Schneider, M.; Schäfer, N.; Bode, C.; Eichhorn, L.; Giordano, F.A.; Güresir, E.; Heimann, M.; Ko, Y.-D.; Landsberg, J.; Lehmann, F.;
et al. The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival. J. Clin. Med. 2021, 10, 4013.
https://doi.org/10.3390/jcm10174013
AMA Style
Schneider M, Schäfer N, Bode C, Eichhorn L, Giordano FA, Güresir E, Heimann M, Ko Y-D, Landsberg J, Lehmann F,
et al. The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival. Journal of Clinical Medicine. 2021; 10(17):4013.
https://doi.org/10.3390/jcm10174013
Chicago/Turabian Style
Schneider, Matthias, Niklas Schäfer, Christian Bode, Lars Eichhorn, Frank A. Giordano, Erdem Güresir, Muriel Heimann, Yon-Dschun Ko, Jennifer Landsberg, Felix Lehmann,
and et al. 2021. "The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival" Journal of Clinical Medicine 10, no. 17: 4013.
https://doi.org/10.3390/jcm10174013
APA Style
Schneider, M., Schäfer, N., Bode, C., Eichhorn, L., Giordano, F. A., Güresir, E., Heimann, M., Ko, Y.-D., Landsberg, J., Lehmann, F., Radbruch, A., Schaub, C., Schwab, K. S., Weller, J., Herrlinger, U., Vatter, H., & Schuss, P.
(2021). The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival. Journal of Clinical Medicine, 10(17), 4013.
https://doi.org/10.3390/jcm10174013
